Future perspectives in COPD

Respiratory Medicine

Volumn 99, Issue SUPPL. 2, 2005, Pages

  Celli, Bartolome ^a   Goldstein, Roger ^b   Jardim, José ^c   Knobil, Katharine ^d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d GLAXOSMITHKLINE   (United States)

Author keywords

BODE; COPD; Fluticasone propionate; International COPD genetics network; Oxidative stress; Pulmonary rehabilitation; Salmeterol; Systemic inflammation; Tiotropium; TORCH; UPLIFT

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; LONG ACTING DRUG; OXYGEN; SALMETEROL; SHORT ACTING DRUG; TIOTROPIUM BROMIDE;

AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CORRELATION ANALYSIS; COST UTILITY ANALYSIS; DISEASE CLASSIFICATION; DYSPNEA; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; GENETIC RISK; HEALTH CARE COST; HUMAN; INFLAMMATION; LUNG EMPHYSEMA; LUNG INFLATION; MEDICAL RESEARCH; METABOLISM; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REHABILITATION MEDICINE; SCORING SYSTEM; SOCIOECONOMICS;

ADRENERGIC BETA-AGONISTS; BRONCHODILATOR AGENTS; EXERCISE THERAPY; FORECASTING; GLUCOCORTICOIDS; HUMANS; LUNG; MUSCLE, SKELETAL; NUTRITIONAL STATUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS;

EID: 28244449099     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.09.014     Document Type: Article

References (37)

1. The world health report 2004 - changing history. 2005. Available at: http://www.who.int/whr/2004/en/
2. Pulmonary rehabilitation Thorax 56 2001 827-834
3. J. Vestbo The TORCH (towards a revolution in COPD health) survival study protocol Eur Respir J 24 2004 206-210
4. M.A. Spruit R. Gosselink T. Troosters et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I Thorax 58 2003 752-756
5. A. Couillard F. Maltais D. Saey et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 2003 1664-1669
6. R. Casaburi Skeletal muscle dysfunction in chronic obstructive pulmonary disease Med Sci Sports Exerc 33 2001 S662-S670
7. R.A. Pauwels A.S. Buist P.M. Calverley C.R. Jenkins S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 2001 1256-1276
8. B.R. Celli C.G. Cote J.M. Marin et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005-1012
9. B. Celli G.L. Snider J. Heffner et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Official statement of the American Thoracic Society Am J Respir Crit Care Med 152 1995 S77-S120
10. N. Wolkove E. Dajczman A. Colacone H. Kreisman The relationship between pulmonary function and dyspnea in obstructive lung disease Chest 96 1989 1247-1251
11. K. Nishimura T. Izumi M. Tsukino T. Oga Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD Chest 121 2002 1434-1440
12. E.F. Wouters E.C. Creutzberg A.M. Schols Systemic effects in COPD Chest 121 2002 127S-130S
13. A.M. Schols J. Slangen L. Volovics E.F. Wouters Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1791-1797
14. K. Marquis R. Debigare Y. Lacasse et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 809-813
15. V.M. Pinto-Plata C. Cote H. Cabral J. Taylor B.R. Celli The 6-min walk distance: Change over time and value as a predictor of survival in severe COPD Eur Respir J 23 2004 28-33
16. D.A. Gerardi L. Lovett M.L. Benoit-Connors J.Z. Reardon R.L. ZuWallack Variables related to increased mortality following out-patient pulmonary rehabilitation Eur Respir J 9 1996 431-435
17. C. Landbo E. Prescott P. Lange J. Vestbo T.P. Almdal Prognostic value of nutritional status in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 1999 1856-1861
18. B. Celli R. ZuWallack S. Wang S. Kesten Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes Chest 124 2003 1743-1748
19. C. Casanova C. Cote J.P. de Torres et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 171 2005 591-597
20. D.E. O'Donnell N. Voduc M. Fitzpatrick K.A. Webb Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Eur Respir J 24 2004 86-94
21. A. Fishman F. Martinez K. Naunheim et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema N Engl J Med 348 2003 2059-2073
22. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party Lancet 1 1981 681-686
23. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Nocturnal Oxygen Therapy Trial Group Ann Intern Med 93 1980 391-398
24. F. Maltais A.A. Simard C. Simard J. Jobin P. Desgagnes P. Leblanc Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD Am J Respir Crit Care Med 153 1996 288-293
25. J. Sauleda F. Garcia-Palmer R.J. Wiesner et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1413-1417
26. M. Montes de Oca S.H. Torres J.B. De Sanctis C. Talamo B.R. Celli Systemic inflammation: Relation between oxidative stress and the multiple component staging system BODE in COPD patients Am J Respir Crit Care Med A616 2004
27. D.O. Wilson R.M. Rogers R.M. Hoffman Nutrition and chronic lung disease Am Rev Respir Dis 132 1985 1347-1365
28. K.J. Tracey H. Wei K.R. Manogue et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation J Exp Med 167 1988 1211-1227
29. M. Di Francia D. Barbier J.L. Mege J. Orehek Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease Am J Respir Crit Care Med 150 1994 1453-1455
30. D.D. Sin P. Lacy E. York S.F. Man Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 760-765
31. A.J. Crockett J.M. Cranston J.R. Moss J.H. Alpers Survival on long-term oxygen therapy in chronic airflow limitation: From evidence to outcomes in the routine clinical setting Intern Med J 31 2001 448-454
32. P.W. Jones F.H. Quirk C.M. Baveystock P. Littlejohns A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire Am Rev Respir Dis 145 1992 1321-1327
33. M. Decramer B. Celli D.P. Tashkin et al. Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: The Uplift trial J Chronic Obstructive Pulmonary Dis 1 2004 303-312
34. J. Bourbeau M. Julien F. Maltais et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: A disease-specific self-management intervention Arch Intern Med 163 2003 585-591
35. T.L. Griffiths M.L. Burr I.A. Campbell et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial Lancet 355 2000 362-368
36. A. Domingo-Salvany R. Lamarca M. Ferrer et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 680-685
37. J.B. Bowen J.J. Votto R.S. Thrall et al. Functional status and survival following pulmonary rehabilitation Chest 118 2000 697-703